Long-Term Safety of Risankizumab in Patients With Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Long-Term Safety of Risankizumab From 17 Clinical Trials in Patients With Moderate-to-Severe Plaque Psoriasis
Br J Dermatol 2021 Oct 15;[EPub Ahead of Print], KB Gordon, M Lebwohl, KA Papp, H Bachelez, JJ Wu, RG Langley, A Blauvelt, B Kaplan, M Shah, Y Zhao, R Sinvhal, K ReichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.